Six azole-derivative antifungal compounds affected several aspects of Candida albicans hyphal development with only a relatively small degree of inhibition of growth rate, measured in terms of ATP concentration, whereas amphotericin B and 5-fluorocytosine affected morphology only when they also substantially inhibited fungal growth rate. At lop8 M, all the azoles tested inhibited branch formation by C. albicans hyphae. At lo-' M and higher concentrations, clotrimazole and miconazole strongly suppressed emergence of new hyphal outgrowths from parent yeast cells, whereas ICI 153066 and itraconazole had little effect on this phenomenon and ketoconazole and tioconazole had intermediate effects. At the highest concentrations tested ( M) hyphal development was ultimately arrested by the azole compounds and the fungus grew predominantly in the form of budding yeast cells; however, none of the azole antifungals prevented initial emergence of an apparently normal germ tube. The antifungals only exerted their morphological effects when they were present in the culture medium: removal of the compounds after exposure of C. albicans to them led to reversion to normal growth.
( M) hyphal development was ultimately arrested by the azole compounds and the fungus grew predominantly in the form of budding yeast cells; however, none of the azole antifungals prevented initial emergence of an apparently normal germ tube. The antifungals only exerted their morphological effects when they were present in the culture medium: removal of the compounds after exposure of C. albicans to them led to reversion to normal growth.
I N T R O D U C T I O N
Various imidazole-derivative antifungal agents have been claimed to inhibit the morphological transformation of Candida albicans from budding yeast cells to hyphae (Borgers et al., 1979; Borgers, 1980; Davies & Marriott, 1981) . However, this inhibitory effect is not unequivocal. Johnson et al. (1982) were unable to detect any inhibition of germ tube outgrowth by ketoconazole in serum, and Davies & Marriott (1 98 1) saw inhibition of hyphal extension by low concentrations of tioconazole or ketoconazole only when the drugs were added with the yeast inoculum: there was no inhibition of extension of preformed germ tubes even when drugs were added at 100 times the concentration that inhibited germ tube initiation.
Since substances with definable and specific effects on morphological changes in C. albicans would be of obvious value in elucidating the mechanisms determining such changes, there is a case for further study of the effects of imidazole antifungals and the newer triazole compounds on C. albicans morphogenesis. Most investigators of morphological change in this fungus have studied only the early stages of the process -emergence of hyphal germ tubes from stationary phase yeast cells -although later events in hyphal development, such as formation of hyphal branches or lateral buds from sites adjacent to hyphal septa, also merit attention as morphogenetic processes (Odds, 1985) . The present study was therefore undertaken to establish whether one or more of several antifungal azole compounds might be sufficiently selective in its effects on morphogenetic processes to be a useful probe for further study of the processes. The study was confined to relatively low concentrations of antifungals since the aim was to demonstrate possible morphological effects that were detectable in cells whose overall growth rate was unaltered by the antifungals. Ahbreiiation : EMEM, Eagle's minimal essential medium.
F . C . ODDS A N D O T H E R S

METHODS
Fungi andgroLi>th conditions. C. ulbicans isolate 731055 (originally obtained from a vaginal swab) was used in the experiments. The fungus was maintained on Sabouraud's dextrose agar (Oxoid) and inocula were grown overnight in this medium and prepared by suspension of the yeast cells in sterile water. Concentrations of yeast cells were determined by haemocytometer counts.
C. ulhicuns was grown in its hyphal form in Eagle's minimal essential medium (EMEM) containing glutamine (Gibco) buffered at pH 7.3 with 0.02 M-HEPES and NaHCO, and incubated at 37 "C under 5% CO, in air. Serum was not included in the medium since the object of the experiments was to allow inhibitory compounds to express their effects on morphology maximally; protein binding of the compounds might be expected to complicate the experiments. The medium was prewarmed to 37 "C, inoculated to a yeast cell concentration of lo6 ml-', dispensed in I ml lots in the wells of Repli-dishes (Sterilin) and incubated statically. Unless otherwise stated, antifungal stock solutions or their solvents were added to the medium just before inoculation. Samples of cultures were taken at intervals by resuspension of the contents of a Repli-dish well with a magnetic stirrer and a small wire follower (Odds, 1982) . Samples (0.5 ml) were treated immediately for extraction of ATP (see below). To the remaining 0.5 ml was added 50 p1 of preservative [sodium dodecyl sulphate, 100 g I-' in 10% (viv) formalin] and the samples were stored at room temperature for subsequent microscopic examination.
In experiments where antifungal drugs were removed from cultures at intervals after inoculation, the procedure was as follows. Cultures (1 0 ml) were set up in 25 ml glass universal bottles. At the time of drug removal the cultures were centrifuged at 2500g for 3 min, the supernatants were discarded and the fungi were washed in antifungal-free E M E M then resuspended in 10 ml antifungal-free EMEM. Parallel cultures were washed and resuspended in fresh medium containing the same antifungal concentration as before to act as controls for the centrifugation/resuspension procedures. Results from the latter showed there was no measurable effect of the procedures on the growth rates or morphology of C. albicuns.
Aniifiuzgal compounds. Six azole antifungals and two non-azole compounds were tested for their effects on C. alhicans growth and morphology. Clotrimazole (Bayer), ICI 153066 (ICI Pharmaceuticals), itraconazole, ketoconazole and miconazole (Janssen Pharmaceutical), and tioconazole (Pfizer) were kindly supplied by their manufacturers. Amphotericin B and 5-fluorocytosine were purchased from Sigma. The antifungals were prepared as stock solutions at 100 times their final test concentrations in DMSO and stored at -20 "C when not in use.
Mtmurement qf'hiomuss and morphology qfC. ulbicans. Preliminary experiments showed that the effects of azole anti fungals were reflected predominantly in altered dimensions of the C. ulbicans hyphae, numbers of branches per mycelium, numbers of yeast cells per mycelium, numbers of hyphal outgrowths per inoculum yeast cell, and hyphal growth rate (in terms of increase in ATP content). These parameters were therefore assessed for all samples.
Growth rates were determined by a least-squares regression analysis of plots of log fungal ATP concentration versus time. ATP was extracted from the fungal cells and ATP hydrolases inactivated by addition of 0.5ml samples to 5 ml lots of Tris/EDTA buffer heated in a boiling water bath (Odds, 1982) . ATP concentrations were determined by bioluminescence photometry (Odds, 1982) . ATP concentrations in C. albicans have been shown to correlate well with alternative estimations of viable biomass (Ansehn & Nilsson, 1984 ; F. C. Odds, unpublished data).
Hyphal lengths and widths were determined by phase-contrast microscopic examination of 25 mycelia from each sample with the aid of a calibrated eyepiece graticule. Only the lengthsof primary hyphae were measured, i.e. those that appeared to be longest and attached to a large, phase-bright yeast cell, presumed to be the original yeast parent cell from the inoculum. In some drug-treated cultures differentiation between primary hyphal elements and other, pleomorphic types of growth was inevitably subjective (see e.g. Figs I h and l c ) .
Numbers of hyphal branches were estimated for the same 25 mycelia that were used for determination of hyphal length, and the number of branches per hypha was calculated. Numbers of hyphal outgrowths per parent yeast cell were determined separately by counting a minimum of 30 mycelia, and the number of yeast cells (other than parent yeast cells) per mycelium was assessed on the basis of haemocytometer counts. Reductions in growth rate, mean hyphal length, hyphal outgrowths per parent yeast cell and branches per mycelium were calculated for each culture as percentages relative to the data for drug-free controls.
R E S U L T S
Microscopic appearance of drug-treated cultures
In antifungal-free cultures in EMEM the pattern of growth of C. albicans was typical of the hyphal growth form of the fungus. After 1 h germ tubes had emerged from most of the inoculum yeast cells. The germ tubes elongated into hyphae, and the earliest hyphal branches were formed after 3-4 h. The hyphae were predominantly phase-dark, but the parent yeast cells remained phase-bright throughout the observation period. By 5 h secondary hyphal shoots had formed from approximately 80% of the parent yeast cells.
Azole eflects on Candida albicans hyphae 2583 The gross effects of azole antifungals on C. albicans hyphal morphology could be seen by qualitative microscopic observation of the cultures. For all the azole compounds tested there was a tendency for cells grown in the presence even of drug concentrations as low as lo-* M to appear phase-bright, unlike the control hyphae (Figs 1 a to 1 J'). A second effect common to the azole antifungals was a substantial inhibition of hyphal branching: hyphae grown in the presence of azoles consistently emerged as phase-dark germ tubes in the same manner as control hyphae during the first 2-3 h of growth, but in their subsequent development they turned pleomorphic and generated lateral buds instead of hyphal branches (Figs 1 c and 1 e) . At the highest azole concentrations hyphal development was sometimes arrested substantially after initial germ tube formation, and growth continued in the form of budding yeast cells that commonly remained in clumps.
Another effect of the azole antifungals was seen with some but not all of the compounds, and was most evident at the highest drug concentrations tested. This effect was an apparent failure of the original parent yeast cells to initiate new hyphal outgrowths -predominantly budding cells were formed from the parent after the initial (first-generation) germ tube emerged (Fig. 1 b) . In general, at the two highest drug concentrations tested (lops and M) hyphal development appeared to be virtually abolished after an initial germ tube outgrowth, whereas at lo-' and lo-* M hyphal extension appeared to be retarded, and the hyphal shape was less regular than in controls, but hyphal development was not arrested completely. Ejects of antifingals on rates of hyphal A TP increase M appeared to have little or no effect on the growth curves of C. albicans hyphae, where ATP concentration was used as a measure of fungal biomass (Fig. 2a) , although regression analysis of the growth curves revealed there was in fact some inhibition of growth rate at all test concentrations above M (Table 1) . By contrast, amphotericin B was entirely non-inhibitory at M and entirely inhibitory at higher concentrations ( Table 1) . Only clotrimazole and ketoconazole appeared to cause any inhibition of biomass growth rates at M, and, except for ICI 153066, the extent to which growth rates were reduced by azole concentrations from M was essentially similar and virtually independent of dose-related effects. A generally greater degree of growth rate inhibition was evident at drug concentrations of M. ICI 153066 was rather more inhibitory than the other azole compounds at concentrations from to M. 5-Fluorocytosine inhibited growth rate to an extent that was proportional to the drug concentration from lo-' to Azole antifungals at concentrations from to to M. 
Eoucts qf antifungals on hyphal length
The inhibitory effects of the antifungals on hyphal length correlated broadly with their effects on rates of ATP increase (Table 2) (Figs 2c and 2 4 . At lo-", tioconazole caused a greater reduction in hyphal length than at 1 0 -h~ and lower concentrations, while the inhibitory effects of 1 OWs M-itraconazole were little different from those at the lower concentrations. The other four azole antifungals inhibited hyphal lengths in patterns similar to those of either tioconazole or itraconazole (Table 2) . Thus there were negligible effects at M, a roughly equal inhibitory effect from lops to M, and differences only at lo-' M, where clotrimazole, ketoconazole, miconazole and tioconazole reduced hyphal length by at least 500, more than at lower concentrations, whereas ICI 153066 and itraconazole were only 3 and IS%, respectively, more inhibitory at 1 0 -5~ than at lower concentrations ( Table 2) .
The data concerning percentage inhibition of hyphal length for amphotericin B and 5-fluorocytosine at lo-' M to lop5 M were of the same order as the growth rate inhibition data for these compounds (Tables I and 2 ), whereas the data for the azole antifungals suggested they often inhibited hyphal length more than growth rate. This difference was accounted for by an increased tendency for the mycelia to initiate yeast cell growth by lateral budding in the presence of azole compounds (Table 3) , and by an increase in average hyphal diameter of 12 to 3204. The numbers of secondary yeast cells and the increase in hyphal diameter were usually greatest at the highest antifungal concentrations tested. Only ICI 153066 and itraconazole at lo-' M caused a relatively small increase in numbers of non-primary yeast cells. This observation correlated with the data on hyphal length inhibition by these two compounds (Tables 2 and 3 ). Ejects qf'nntijhngals on hyphal branching of' C. albicans At least a 23% reduction in the number of branches formed per mycelium was observed at all azole concentrations tested except for clotrimazole and ICI 153066, which appeared not to affect branching at lop9 M. For all azole compounds, hyphal branching was inhibited by 86 to 100% at concentrations from M ( Table 4) . Inhibition of branch formation of this order was seen with amphotericin B and 5-fluorocytosine only at concentrations where growth rates were inhibited by 50% or more (Tables 1 and 4) . The data in Table 4 are amplified by the detailed time courses of branch formation shown for one of the test compounds in Fig. 2(b) . The time at which branching commenced was the same in the presence and in the absence of the antifungals, but the extent to which branches were formed was markedly reduced in the presence of the azole compounds.
M to
EBects oj'antifunguls on secondary hyphul outgrowths from parent yeast cells
Of all the inhibitory effects of azole antifungals on C. albicans hyphae, prevention of outgrowths of secondary and later hyphae from the original parent yeast cells was the property that revealed variation in the effects of the individual compounds (Table 5 ). Clotrimazole and miconazole reduced the number of hyphal outgrowths by more than 70% at concentrations of M and higher. Ketoconazole and tioconazole were somewhat less inhibitory than clotrimazole and miconazole at lop7 M, but they were similarly inhibitory at lop8 M. ICI 153066 and itraconazole had relatively little effect on secondary hyphal outgrowths at concentrations below M. Amphotericin B and 5-fluorocytosine had this particular inhibitory effect only at concentrations that also caused substantial inhibition of biomass increase (Table 1) . 
Signlficunce of time c?f uiia'itions or remoiwl of' antifungal on deiielopment of' C. albicans hyphae
Ketoconazole at lo-' M was selected as representative of the effects of azole antifungals on C. albiccins hyphal development to investigate the effects of addition or removal of the drug at various times before and after the 'zero time' additions used in the previously described experiments. Inhibition of hyphal branching and growth rate were measured as the most sensitive indicators of the range of effects of ketoconazole. The results (Table 6) suggested that ketoconazole was an effective inhibitor only when it was present in the culture. Its addition at times later than 0 h caused progressively less inhibition of growth rate and branch formation. When the antifungal was removed from the culture at intervals its inhibitory effects on biomass growth rate and branching were generally greater the longer the period of exposure of fungus to antifungal. It was, however. notable that hyphal branching was reduced by43% even in cultures that had been exposed to ketoconazole for only the first hour of growth (Table 6) : the time at which branches first appeared was at least 2 h later than this.
D I S C U S S I O N
The results of this study confirm previous reports that imidazole antifungals can affect the morphological development of C. albicans hyphae (Borgers et al., 1979; Borgers, 1980; Davies & Marriott, 1981) . They show that triazole antifungals exert similar effects and they define more precisely than before the nature of the steps in morphogenesis that are affected by azole anti fungal compounds. At very low concentrations, all the azole antifungals tested substantially inhibited hyphal branching. but none of them prevented emergence of a normal germ tube in the earliest stages of growth. Some of the compounds appeared to prevent additional hyphal outgrowths from parent yeast cells, thus favouring emergence of budding yeast cells. At the highest concentration tested, M, most of the azoles tested caused substantial inhibition of hyphal length with concomitant enforcement of growth in the shape of budding yeast cells. The yeast cells commonly appeared not to separate, suggesting that the non-separation mechanism characteristic of hyphae might still be operating, but this possibility was not specifically investigated. Although none of these morphological effects were fully expressed in the absence of some inhibition of hyphal growth rate, the extent of inhibition of growth rate was substantially less than that of the morphological changes. The two control non-azole antifungals amphotericin B and 5-fluorocytosine had similar apparent morphological effects only when hyphal growth rate was also substantially reduced, and these effects are therefore considered non-specific to morphogenesis.
Two primary modes of action have been proposed for azole antifungals against C. afbicans. The first is an effect on cytochrome P-450 (Van den , which is probably the cause of an inhibition of ergosterol biosynthesis that results in accumulation of 14-a-methyl sterols in the plasma membrane. The second effect is a direct interaction of the drugs with membrane lipids, leading to membrane damage (Van den Bossche et af., l983), which is probably the result of changes in the lipid transition temperature (Van den Bossche et af., 1982) . Interaction with cytochrome P-450 and inhibition of ergosterol synthesis in yeast cells have been demonstrated for several azoles at concentrations of the order of 5 x lo-* M to 5 x M (Marriott, 1980; Van den Bossche etaf., 1978 , 1982 whereas direct membrane damage requires higher azole concentrations -at least M and usually lo-' M or more (Sreedhara Swamy et af., 1974; Cope, 1980; Sud & Feingold, 1981 Uno et af., 1982; Van den Bossche et al., 1983 . A slow-acting inhibitory effect of miconazole and ketoconazole on membrane fatty acid synthesis in C. afbicaizs has been proposed, but little of the evidence for this has been formally published (Van den Bossche et af., 1983) .
The lowest antifungal concentrations known to have an effect on the cytochrome P-450 target in cell-free systems are of precisely the same order as the lowest concentrations that affected branch development of C. albicans in the present study (Table 4) . Inhibition of growth rate (Table 1 ) was lowest at the lowest antifungal concentrations; some inhibition of growth rate at concentrations as low as lo-* M has been noted before (Van den Bossche et al., 1980) . The impression gained is therefore that the effects of the azole antifungals on hyphal branching may be related mainly to the effects of the drugs on cytochrome P-450. Because inhibition of hyphal extension and secondary hyphal shoot formation are seen only at higher drug concentrations and principally with drugs known to possess the capability for direct membrane damage, these effects probably result mainly from direct interactions of the compounds with the fungal cell membranes. All the known membrane changes caused directly and indirectly in azole-treated C. afbicans are likely to alter the fluidity of the plasma membrane (Van den Bossche et al., 1983) . Because several of the enzymes involved in C. afbicans cell wall synthesis are located in the cell membrane (Braun & Calderone, 1978; Marriott, 1975; Chiew et af., 1980) it is possible that changes in membrane fluidity could affect the activity of these enzymes and their regulation, and thus lead to distorted cell wall synthesis with concomitant changes in cell shape. The fact that the azole compounds at low concentrations have an effect selectively related to hyphal branching presumably depends on a different mechanism, possibly related to the known effects of azole antifungals on cytochrome P-450 and sterol synthesis.
In some fungi with an entirely hyphal mode of development, such as Neurospora crassa, regulation of branch formation has been shown to depend on a Ca'+/cyclic AMP mechanism, which is affected by ionophores such as A23187 (Reissig & Kinney, 1983) . The possibility that azole antifungals affect a similar mechanism awaits investigation. It has been postulated that hyphal branching of C. afbicans is a process regulated by gene expression whereas overall cell shape is regulated mainly at the phenotypic level by environmental influences on cell wall synthesizing enzymes (Odds, 1985) . The fact that the azole compounds tested in the present
